首页|期刊导航|现代中西医结合杂志|miR-548b靶向调控APC2对结直肠癌进展的影响

miR-548b靶向调控APC2对结直肠癌进展的影响OA

Effect of miR-548b targeting regulation of APC2 on the progression of colorectal cancer

中文摘要英文摘要

目的 探讨 miR-548b 在结直肠癌中的表达特征及其靶向调控腺瘤性结肠息肉病蛋白2(APC2)对结直肠癌细胞侵袭和增殖的影响.方法 ①收集 2021 年 1 月—2022 年 12 月在河北医科大学第二医院手术并经病理证实的60 例结直肠癌患者配对癌组织及癌旁正常组织标本,采用 qRT-PCR 法检测组织标本中 miR-548b 表达情况,比较 miR-548b 高表达和低表达患者临床特征.②培养结直肠癌细胞系 SW480、HT29、SW620、HCT116、LOVO 及正常肠上皮细胞 FHC,通过qRT-PCR 法检测细胞中miR-548b 表达情况,筛选高表达miR-548b 的SW620 细胞进行后续实验.实验设miR-548b 模拟物组和NC 组,Transwell 和MTT 实验评估miR-548b 对SW620 细胞侵袭和增殖的影响.生物信息学预测 miR-548b 靶基因,并通过荧光素酶报告基因和 Western blot法检测验证miR-548b 与APC2 的靶向调控关系.结果 结直肠癌患者癌组织中miR-548b 相对表达量明显高于癌旁正常组织(P<0.05),且 miR-548b 高表达患者出现淋巴结转移及 Duckes 分期 C+D 期的比例均明显高于 miR-548b 低表达患者(P 均<0.05).miR-548b 模拟物组细胞侵袭数量明显多于 NC 组(P<0.05),培养48 h 和72 h miR-548b 模拟物组细胞存活率均明显高于NC 组(P 均<0.05).APC2 被证实为 miR-548b 的直接靶基因,且 miR-548b 模拟物组细胞中APC2 蛋白相对表达量明显低于 NC 组(P<0.05).结论 miR-548b 在结直肠癌组织中高表达,其可通过靶向抑制 APC2 促进肿瘤细胞侵袭和增殖,提示其可作为结直肠癌潜在的诊断及治疗靶点.

Objective It is to investigate the expression characteristics of miR-548b in colorectal cancer(CRC)and its effect on the invasion and proliferation of CRC cells via targeting regulation of adenomatous polyposis coli protein 2(APC2).Methods ①Paired tumour and adjacent non-cancerous tissue samples were collected from 60 CRC patients un-dergoing surgical resection and pathologically confirmed at the Second Hospital of Hebei Medical University from January 2021 to December 2022,the expression of miR-548b in tissue samples was detected by qRT-PCR,and the clinical charac-teristics of patients with high and low expressions of miR-548b were compared.②The CRC cell lines SW480,HT29,SW620,HCT116,LOVO and normal intestinal epithelial cells FHC were cultured,the expression of miR-548b in the cells was detected by qRT-PCR,The SW620 cells with high expression of miR-548b were screened for the subsequent experi-ments.A miR-548b mimic group and a normal control(NC)group were set up in the experiment,the effects of miR-548b on the invasion and proliferation of SW620 cells were evaluated by Transwell and MTT assays.The miR-548b target genes were predicted by Bioinformatics analysis,and the targeting regulatory relationship between miR-548b and APC2 was vali-dated by luciferase reporter assay and Western blot analysis.Results The relative expression of miR-548b in tumor tissues of CRC patients was significantly higher than that in adjacent normal tissues(P<0.05),furthermore,the proportions of patients with lymph node metastasis and those with Dukes'stage C or D were significantly higher in the miR-548b high-ex-pression group than those in the miR-548b low-expression group(all P<0.05 for).The number of invading cells in the miR-548b mimic group was significantly higher than that in the NC group(P<0.05),and the cell survival rates in the miR-548b mimic group after 48 and 72 hours of culture were both significantly higher than those in the NC group(both P<0.05).APC2 was confirmed to be a direct target gene of miR-548b,and the relative expression of APC2 protein in the miR-548b mimic group was significantly lower than that in the NC group(P<0.05).Conclusion MiR-548b is highly ex-pressed in CRC tissue and it can promote the invasion and proliferation of tumor cells via targeting inhibition of APC2,this suggests that it may serve as a potential diagnostic and therapeutic target for CRC.

郝英豪;张国建;任鹏涛;黄炜;李猛;阎庆辉;任欢

河北医科大学第二医院,河北 石家庄 050000河北医科大学第二医院,河北 石家庄 050000河北医科大学第二医院,河北 石家庄 050000河北医科大学第二医院,河北 石家庄 050000河北医科大学第二医院,河北 石家庄 050000河北医科大学第二医院,河北 石家庄 050000河北医科大学第二医院,河北 石家庄 050000

医药卫生

miR-548b结直肠癌APC2侵袭增殖

miR-548bcolorectal cancerAPC2invasionproliferation

《现代中西医结合杂志》 2026 (6)

766-771,6

河北省医学科学研究课题计划项目(20211335)

10.3969/j.issn.1008-8849.2026.06.006

评论